Genentech Inc.
Industry / private company
Location:
San Francisco, CA,
United States (USA) (US)
ISNI: 0000000405344718
ROR: https://ror.org/011qkaj49
EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors (2018)
Stankovic ND, Bicker F, Keller S, Jones DTW, Harter PN, Kienzle A, Gillmann C, et al.
Journal article
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial (2018)
Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, et al.
Journal article
ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL (2018)
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al.
Conference contribution
OPTIMAL DOSE OF TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS: EFFICACY, SAFETY, AND EXPOSURE-EFFICACY ANALYSIS FROM GIACTA (2017)
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Mallalieu NL, Aringer M, Blockmans D, et al.
Conference contribution
Trial of Tocilizumab in Giant-Cell Arteritis (2017)
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al.
Journal article
Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2016)
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al.
Conference contribution
Notch3 signalling promotes tumour growth in colorectal cancer (2011)
Serafin V, Persano L, Moserle L, Esposito G, Ghisi M, Curtarello M, Bonanno L, et al.
Journal article